m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00058)
| Target Name | hsa_circ_0021427 (circ_HPS5) | ||||
|---|---|---|---|---|---|
| Gene Name | Circ_HPS5 | ||||
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
Circ_HPS5
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | In hepatocellular carcinoma, METTL3 could direct the formation of hsa_circ_0021427 (circHPS5), and specific m6A controlled the accumulation of circHPS5. YTHDC1 facilitated the cytoplasmic output of circHPS5 under m6A modification. CircHPS5 can act as a miR-370 sponge to regulate the expression of HMGA2 and further accelerate hepatocellular carcinoma cell tumorigenesis. | |||
| Target Regulation | Up regulation | |||
| Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
| Pathway Response | Transcriptional misregulation in cancer | hsa05202 | ||
| Cell Process | Epithelial-mesenchymal transition | |||
| Cell autophagy | ||||
| In-vitro Model | Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens | CVCL_0326 |
| L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
| In-vivo Model | To create the xenograft neoplasm system, 40 male BALB/c nude mice aged 5 weeks were randomly separated into sh-NC, sh-circHPS5, sh-circHPS5+CTRL, and sh-circHPS5+SAH groups (n = 5 for each group). HCC cells were subcutaneously injected into the axilla of the nude mice. | |||
YTH domain-containing protein 1 (YTHDC1) [READER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | In hepatocellular carcinoma, METTL3 could direct the formation of circHPS5, and specific m6A controlled the accumulation of circHPS5. YTHDC1 facilitated the cytoplasmic output of hsa_circ_0021427 (circHPS5) under m6A modification. CircHPS5 can act as a miR-370 sponge to regulate the expression of HMGA2 and further accelerate hepatocellular carcinoma cell tumorigenesis. | |||
| Target Regulation | Up regulation | |||
| Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
| Pathway Response | Transcriptional misregulation in cancer | hsa05202 | ||
| Cell Process | Epithelial-mesenchymal transition | |||
| Cell autophagy | ||||
| In-vitro Model | Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens | CVCL_0326 |
| L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
| In-vivo Model | To create the xenograft neoplasm system, 40 male BALB/c nude mice aged 5 weeks were randomly separated into sh-NC, sh-circHPS5, sh-circHPS5+CTRL, and sh-circHPS5+SAH groups (n = 5 for each group). HCC cells were subcutaneously injected into the axilla of the nude mice. | |||
Liver cancer [ICD-11: 2C12]
| In total 2 item(s) under this disease | ||||
| Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | In hepatocellular carcinoma, METTL3 could direct the formation of hsa_circ_0021427 (circHPS5), and specific m6A controlled the accumulation of circHPS5. YTHDC1 facilitated the cytoplasmic output of circHPS5 under m6A modification. CircHPS5 can act as a miR-370 sponge to regulate the expression of HMGA2 and further accelerate hepatocellular carcinoma cell tumorigenesis. | |||
| Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
| Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
| Target Regulation | Up regulation | |||
| Pathway Response | Transcriptional misregulation in cancer | hsa05202 | ||
| Cell Process | Epithelial-mesenchymal transition | |||
| Cell autophagy | ||||
| In-vitro Model | Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens | CVCL_0326 |
| L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
| In-vivo Model | To create the xenograft neoplasm system, 40 male BALB/c nude mice aged 5 weeks were randomly separated into sh-NC, sh-circHPS5, sh-circHPS5+CTRL, and sh-circHPS5+SAH groups (n = 5 for each group). HCC cells were subcutaneously injected into the axilla of the nude mice. | |||
| Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | In hepatocellular carcinoma, METTL3 could direct the formation of circHPS5, and specific m6A controlled the accumulation of circHPS5. YTHDC1 facilitated the cytoplasmic output of hsa_circ_0021427 (circHPS5) under m6A modification. CircHPS5 can act as a miR-370 sponge to regulate the expression of HMGA2 and further accelerate hepatocellular carcinoma cell tumorigenesis. | |||
| Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
| Target Regulator | YTH domain-containing protein 1 (YTHDC1) | READER | ||
| Target Regulation | Up regulation | |||
| Pathway Response | Transcriptional misregulation in cancer | hsa05202 | ||
| Cell Process | Epithelial-mesenchymal transition | |||
| Cell autophagy | ||||
| In-vitro Model | Hep 3B2.1-7 | Childhood hepatocellular carcinoma | Homo sapiens | CVCL_0326 |
| L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
| In-vivo Model | To create the xenograft neoplasm system, 40 male BALB/c nude mice aged 5 weeks were randomly separated into sh-NC, sh-circHPS5, sh-circHPS5+CTRL, and sh-circHPS5+SAH groups (n = 5 for each group). HCC cells were subcutaneously injected into the axilla of the nude mice. | |||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Regulator
Histone modification
m6A Regulator: YTH domain-containing protein 1 (YTHDC1)
| In total 1 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT03483 | ||
| Epigenetic Regulator | Histone acetyltransferase p300 (P300) | |
| Regulated Target | Histone H3 lysine 18 lactylation (H3K18la) | |
| Crosstalk relationship | Histone modification → m6A | |
| Disease | Liver cancer | |
Non-coding RNA
m6A Regulator: Methyltransferase-like 3 (METTL3)
| In total 1 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT05532 | ||
| Epigenetic Regulator | hsa_circ_0021427 (Circ_HPS5) | |
| Regulated Target | hsa-miR-370-3p | |
| Crosstalk relationship | m6A → ncRNA | |
| Disease | Liver cancer | |
m6A Regulator: YTH domain-containing protein 1 (YTHDC1)
| In total 1 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT05533 | ||
| Epigenetic Regulator | hsa_circ_0021427 (Circ_HPS5) | |
| Regulated Target | hsa-miR-370-3p | |
| Crosstalk relationship | m6A → ncRNA | |
| Disease | Liver cancer | |